Strata Critical Medical, Inc.

For the period ended Mar 31, 2025. Filed May 12, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 12, 2025

SRTA$6.05+8.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Cover page Table of Contents

PART I. FINANCIAL INFORMATION

Item 1. Financial statements

Unaudited Interim Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024 Unaudited Interim Notes to Unaudited Interim Item 2. Management’s discussion and analysis of financial condition and results of operations Item 3. Quantitative and qualitative disclosures about market risk Item 4. Controls and procedures

PART II. OTHER INFORMATION

PART II. OTHER INFORMATION Item 1A. Risk factors

Item 2. Unregistered sales of equity securities, use of proceeds and Issuer purchases of equity securities (no text here)

Item 3. Defaults upon senior securities (no text here)

Item 4. Mine safety disclosures (no text here)

Item 5. Other information Item 6. Exhibits SIGNATURES

FORM 10-Q

TABLE OF CONTENTS

Page
PART I. FINANCIAL INFORMATION	3
Item 1.	Financial statements	3
	Unaudited Interim Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024	3
	Unaudited Interim Condensed Consolidated Statements of Operations for the three months ended March 31, 2025 and 2024	4
	Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss for the three months ended March 31, 2025 and 2024	5
	Unaudited Interim Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2025 and 2024	6
	Unaudited Interim Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2025 and 2024	7
	Notes to Unaudited Interim Condensed Consolidated Financial Statements	8
Item 2.	Management’s discussion and analysis of financial condition and results of operations	20
Item 3.	Quantitative and qualitative disclosures about market risk	35
Item 4.	Controls and procedures	35
PART II. OTHER INFORMATION	36
Item 1.	Legal proceedings	36
Item 1A.	Risk factors	36
Item 2.	Unregistered sales of equity securities, use of proceeds and Issuer purchases of equity securities	36
Item 3.	Defaults upon senior securities	36
Item 4.	Mine safety disclosures	36
Item 5.	Other information	36
Item 6.	Exhibits	37
SIGNATURES	38

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.